ioGenetics
Stage
Unattributed | AliveTotal Raised
$1.35MLast Raised
$1.15M | 9 yrs agoAbout ioGenetics
ioGenetics combines immunoinformatics and recombinant protein engineering for the design, discovery, and early development of biotherapeutics, vaccines and diagnostics. uTOPE immunoinformatics analysis can assess antigenicity of biopharmaceuticals, and assist optimization and patient stratification. Applications include products for diagnosis or management of infectious diseases, allergy, autoimmunity, and cancer.
Missing: ioGenetics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ioGenetics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing ioGenetics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
ioGenetics is included in 2 Expert Collections, including Health Monitoring & Diagnostics.
Health Monitoring & Diagnostics
2,623 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
ioGenetics Patents
ioGenetics has filed 18 patents.
The 3 most popular patent topics include:
- Immune system
- Immunology
- Clusters of differentiation
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/25/2017 | 9/6/2022 | Flaviviruses, Animal viral diseases, Zoonoses, Hemorrhagic fevers, Viral diseases | Grant |
Application Date | 1/25/2017 |
|---|---|
Grant Date | 9/6/2022 |
Title | |
Related Topics | Flaviviruses, Animal viral diseases, Zoonoses, Hemorrhagic fevers, Viral diseases |
Status | Grant |
Latest ioGenetics News
Jun 7, 2018
June 07, 2018 06:09 AM Eastern Daylight Time This latest pipeline guide provides comprehensive information on the therapeutics under development for Cryptosporidiosis (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The pipeline guide also reviews key players involved in therapeutic development for Cryptosporidiosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Preclinical stages are 4 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 1 and 1 molecules, respectively. Companies Mentioned Products under Development by Universities/Institutes Cryptosporidiosis - Therapeutics Assessment Assessment by Route of Administration Assessment by Molecule Type AbbVie Inc
ioGenetics Frequently Asked Questions (FAQ)
Where is ioGenetics's headquarters?
ioGenetics's headquarters is located at 3591 Anderson Street, Madison.
What is ioGenetics's latest funding round?
ioGenetics's latest funding round is Unattributed.
How much did ioGenetics raise?
ioGenetics raised a total of $1.35M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.